A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Clinical trial NCT06935357 · RECRUITING

Trial details

NCT number: NCT06935357
Sponsor: Biogen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Immunoglobulin A Nephropathy (IgAN)

Start date: 2025-05-08
Primary completion: 2027-05-31
Enrollment: 454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.